Apolipoprotein E Arg136 → Cys mutation and hyperlipidemia in a large central European population sample

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 217-218

  Hubacek, Jaroslav A ^a,b   Peasey, Anne ^c   Pikhart, Hynek ^c   Adamková, Vera ^a   Stavek, Petr ^a   Marmot, Michael ^c   Bobak, Martin ^c   Kubinova, Ruzena ^d  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b Cardiovascular Research Center   (Czech Republic)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d NONE

Author keywords

Apolipoprotein E; Genetics; Lipid metabolism; Rare mutation

Indexed keywords

ATORVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; APOLIPOPROTEIN E GENE; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EUROPE; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERLIPIDEMIA; HYPOLIPEMIA; LETTER; LIPOPROTEIN METABOLISM; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; APOLIPOPROTEINS E; ARGININE; CYSTEINE; EUROPE; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; MUTATION;

EID: 37249040559     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.10.009     Document Type: Letter

References (10)

1. * (Arg136 → Cys) heterozygotes. Physiol Res 49 (2000) 307-314
2. Walden C.C., Huff M.W., Leiter L.A., et al. Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping. J Clin Endocrinol Metab 78 (1994) 699-704
3. Feussner G., Albanese M., Mann W.A., et al. Apolipoprotein E2 (Arg136 → Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia. Eur J Clin Invest 26 (1996) 13-23
4. 136 → Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia. J Lipid Res 39 (1998) 658-669
5. Hubacek J.A., Pitha J., Skodova Z., and Poledne R. Rare variant of apolipoprotein E (Arg136 → Cys) in a subject with normal lipid values. Physiol Res 51 (2002) 107-108
6. *(Arg136 → Cys) gene variant. Physiol Res 52 (2003) 647-650
7. Hubacek J.A., Pitha J., Adamkova V., et al. Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms. Physiol Res 52 (2003) 195-200
8. Hubacek J.A., Skodova Z., Adamkova V., et al. The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 65 (2004) 126-130
9. Peasey A., Bobak M., Kubinova R., et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health 6 (2006) 255
10. Wilson C., Wardell M.R., Weisgraber K.H., et al. Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. Science 252 (1991) 1817-1822